ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,000 | +11.6% | 1,396,555 | +15.1% | 0.01% | +50.0% |
| Q2 2023 | $4,479 | +39.1% | 1,213,735 | +24.7% | 0.01% | +50.0% |
| Q1 2023 | $3,221 | +19.3% | 973,235 | +39.8% | 0.00% | 0.0% |
| Q4 2022 | $2,700 | -99.8% | 695,935 | +9.0% | 0.00% | +100.0% |
| Q3 2022 | $1,551,000 | +8.0% | 638,400 | -12.0% | 0.00% | 0.0% |
| Q2 2022 | $1,436,000 | +49.0% | 725,500 | +37.7% | 0.00% | +100.0% |
| Q1 2022 | $964,000 | +95.9% | 526,700 | +51.0% | 0.00% | 0.0% |
| Q4 2021 | $492,000 | +85.0% | 348,900 | +48.5% | 0.00% | – |
| Q3 2021 | $266,000 | -5.3% | 235,000 | +33.8% | 0.00% | – |
| Q2 2021 | $281,000 | -76.0% | 175,626 | -6.7% | 0.00% | -100.0% |
| Q3 2018 | $1,169,000 | +785.6% | 188,300 | +544.9% | 0.00% | – |
| Q2 2018 | $132,000 | +109.5% | 29,200 | +43.8% | 0.00% | – |
| Q3 2017 | $63,000 | +50.0% | 20,300 | +79.6% | 0.00% | – |
| Q2 2017 | $42,000 | – | 11,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
| Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
| Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
| AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
| Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
| Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
| Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
| TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
| EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |